TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
ProPharma Group Sweden AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
95,804
|
97,444
|
96,813 |
| Financial expenses |
1,446
|
14
|
277 |
| Earnings before taxes |
-3,660
|
-4,982
|
4,822 |
| EBITDA |
-4,254
|
-4,794
|
5,421 |
| Total assets |
66,562
|
52,606
|
44,900 |
| Current assets |
66,036
|
51,936
|
44,055 |
| Current liabilities |
44,417
|
26,801
|
14,113 |
| Equity capital |
19,505
|
22,505
|
26,648 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
57
|
65
|
57 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
29.3%
|
42.8%
|
59.3% |
| Turnover per employee |
1,681
|
1,499
|
1,698 |
| Profit as a percentage of turnover |
-3.8%
|
-5.1%
|
5.0% |
| Return on assets (ROA) |
-3.3%
|
-9.4%
|
11.4% |
| Current ratio |
148.7%
|
193.8%
|
312.2% |
| Return on equity (ROE) |
-18.8%
|
-22.1%
|
18.1% |
| Change turnover |
-1,640
|
631
|
-602 |
| Change turnover % |
-2%
|
1%
|
-1% |
| Chg. No. of employees |
-8
|
8
|
-5 |
| Chg. No. of employees % |
-12%
|
14%
|
-8% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.